Human gut microbiome impacts skeletal muscle mass via gut microbial synthesis of the short‐chain fatty acid butyrate among healthy menopausal women

Abstract

Background Increasing evidence suggests that human gut microbiome plays an important role in variation of skeletal muscle mass (SMM). However, specific causal mechanistic relationship of human gut microbiome with SMM remains largely unresolved. Understanding the causal mechanistic relationship may provide a basis for novel interventions for loss of SMM. This study investigated whether human gut microbiome has a causal effect on SMM among Chinese community-dwelling healthy menopausal women. Methods Estimated SMM was derived from whole-body dual-energy X-ray absorptiometry. We performed integrated analyses on whole-genome sequencing, shotgun metagenomic sequencing, and serum short-chain fatty acids (SCFAs), as well as available host SMM measurements among community-dwelling healthy menopausal women (N = 482). We combined the results with summary statistics from genome-wide association analyses for human gut microbiome (N = 952) and SMM traits (N = 28 330). As a prerequisite for causality, we used a computational protocol that was proposed to measure correlations among gut metagenome, metabolome, and the host trait to investigate the relationship between human gut microbiome and SMM. Causal inference methods were applied to assess the potential causal effects of gut microbial features on SMM, through one-sample and two-sample Mendelian randomization (MR) analyses, respectively. Results In metagenomic association analyses, the increased capacity for gut microbial synthesis of the SCFA butyrate was significantly associated with serum butyrate levels [Spearman correlation coefficient (SCC) = 0.13, P = 0.02] and skeletal muscle index (SCC = 0.084, P = 0.002). Of interest was the finding that two main butyrate-producing bacterial species were both positively associated with the increased capacity for gut microbial synthesis of butyrate [Faecalibacterium prausnitzii (SCC = 0.25, P = 6.6 × 10 À7 ) and Butyricimonas virosa (SCC = 0.15, P = 0.001)] and for skeletal muscle index [F. prausnitzii (SCC = 0.16, P = 6.2 × 10 À4 ) and B. virosa (SCC = 0.17, P = 2.4 × 10 À4 )]. One-sample MR results showed a causal effect between gut microbial synthesis of the SCFA butyrate and appendicular lean mass (β = 0.04, 95% confidence interval 0.029 to 0.051, P = 0.003). Two-sample MR results further confirmed the causal effect between gut microbial synthesis of the SCFA butyrate and appendicular lean mass (β = 0.06, 95% confidence interval 0 to 0.13, P = 0.06). Conclusions Our results may help the future development of novel intervention approaches for preventing or alleviating loss of SMM.

Butyrate to combat obesity and obesity‐associated metabolic disorders: Current status and future implications for therapeutic use

“…A mice model investigating the effect of chronic butyrate administration in aging mice supports above reported effects as butyrate‐reduced intramuscular fat accumulation and increased markers of mitochondrial biogenesis, antioxidant activity, and oxidative metabolism in the skeletal muscle 252 . A human cross‐sectional study using mendelian randomization analysis has identified a causal relationship between the production of microbial butyrate and appendicular lean mass in Chinese menopausal women, suggesting that butyrate may play a role in maintaining muscle mass in humans as well 253 …”

Causal effects of gut microbiota on diabetic retinopathy: A Mendelian randomization study

“…To ensure data robustness and the accuracy of results, the SNPs were quality checked to obtain compliant IVs: (1) SNPs associated with GM taxa reached genome-wide significance threshold ( P <5×10 -8 ). Since the number of eligible IVs ( P <5×10 -8 ) was extremely small, a relatively more comprehensive threshold ( P <1×10 -5 ) ( 20 , 21 ) was selected to obtain a more comprehensive result. (2) To meet the MR assumptions, we performed a linkage disequilibrium (LD) analysis (R 2 <0.001, clumping distance = 10,000kb) based on European-based 1,000 Genome Projects and removed the SNPs that did not meet the requirements.…”

Curcumin Targeting NF-κB/Ubiquitin-Proteasome-System Axis Ameliorates Muscle Atrophy in Triple-Negative Breast Cancer Cachexia Mice

“…Isobutyrate is a kind of short-chain fatty acid. Studies have confirmed that the increase in butyrate synthesis by intestinal microbes is closely related to the increase in skeletal muscle index [ 39 ]. Fatty acids, glucose, and lactic acid can be metabolized into pyruvate, which is transported to the mitochondria by the mitochondrial pyruvate carrier (MPC) for the citric acid cycle [ 40 ].…”